Key facts
- Squadron Capital Management LLC filed SCHEDULE 13G for NextCure, Inc. Common Stock, $0.001 par value per share (NXTC).
- Disclosed ownership: 6.5%.
- Date of event: 21 Oct 2025.
Squadron Capital Management LLC - 21 Oct 2025 SCHEDULE 13G Report for NextCure, Inc. Common Stock, $0.001 par value per share (NXTC)
- Filing Manager
- Squadron Capital Management LLC
- Reporting Manager
- Squadron Capital Management LLC
- Symbol
- NXTC
- Shares outstanding
- 2,674,785 shares
- Disclosed Ownership
- 173,861 shares
- Ownership
- 6.5%
- Form type
- SCHEDULE 13G
- Filing time
- 24 Oct 2025, 16:37:48 UTC
- Date of event
- 21 Oct 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Key filing fact
Squadron Capital Management LLC disclosed 6.5% ownership in NextCure, Inc. Common Stock, $0.001 par value per share (NXTC) on 21 Oct 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 24 Oct 2025, 16:37.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (4)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Squadron Master Fund LP | 5.8% | 154,021 | 0 | 154,021 | /s/ Matthew Sesterhenn | Partner, Squadron Partners LLC, its General Partner | |
| Squadron Capital Management LLC | 6.5% | 173,861 | 0 | 173,861 | /s/ Matthew Sesterhenn | Partner | |
| Matthew Sesterhenn | 6.5% | 173,861 | 0 | 173,861 | /s/ Matthew Sesterhenn | Matthew Sesterhenn | |
| William Blank | 6.5% | 173,861 | 0 | 173,861 | /s/ William Blank | William Blank |
CIK / CUSIP context first